analytica 2022: Fighting COVID-19 with combined expertise

New tools in virus research and detection

22-Mar-2022 - Whether PCR apps or high-tech analysis equipment for vaccine development: during the pandemic, the chemical analysis and biotech sector has demonstrated its strength. From June 21 to 24, 2022, the industry will come together in Munich at analytica, the leading trade fair for analysis, laboratory ...

Life-science start-up Actome and QIAGEN announce commercial partnership

Licensing and co-marketing agreement signed

11-Jan-2022 - Actome GmbH, a life-science start-up company from the University of Freiburg and Hahn-Schickard, Germany has signed a license agreement and a co-marketing agreement with QIAGEN GmbH, Hilden, Germany, to jointly accelerate the market entry of Actome’s Protein-Interaction-Coupling (PICO) ...

Rapid PCR tests at the touch of a button

ETH start-​up diaxxo hope to fundamentally change the way in which PCR testing is deployed in medicine

14-Dec-2021 - ETH researchers Michele Gregorini and Philippe Bechtold have developed a PCR testing device that can easily be used outside the lab – and that takes less than 30 minutes to deliver results. Now the two young entrepreneurs are focusing their efforts on getting the device approved for medical ...

New method leads ten times faster to corona test results

Method not only saves time, but also effort

10-Jul-2020 - Currently, it takes more than two hours to perform and evaluate a test for SARS-CoV-2 - and so a laboratory can only test a very limited number of people per day. Cell biologists at the University of Bielefeld have now developed a method in a study with several cooperation partners that delivers ...

Stilla Technologies completes €16 Million Series A

Novel digital PCR system

23-Nov-2018 - Stilla Technologies, provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion of a Series A financing round of 16 million euros ($18 Million) led by Illumina Ventures, with participation from Kurma Partners, LBO France, BNP ...

QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents

26-Jan-2009 - Corbett, QIAGEN, ltf Labortechnik GmbH & Co. KG, and Applied Biosystems, LLC, part of Life Technologies Corporation announced a settlement of their disputes concerning infringement by Corbett’s Rotor-Gene_TM Real-Time PCR-Cyclers and Applied Biosystems’ Real-Time Thermal Cycler Instrument ...

Enigma Diagnostics signs exclusive licence agreement with the UK Defence Science and Technology Laboratory

24-Aug-2007 - Enigma Diagnostics announced that it has signed a new exclusive licence agreement with the Defence Science and Technology Laboratory (Dstl). The worldwide licence covers a broad range of technologies, including Pyrostart, ResonSense and Temperature Control, which are important elements of ...

Gene Lab To Go

Reasonably priced and battery-driven: a pocket PCR device

02-May-2007 - A huge number of diagnostic techniques are based on PCR (the polymerase chain reaction): the use of PCR allows even the tiniest amounts of genetic material to be duplicated so that it can be analyzed. This should make things such as the rapid and reliable identification of a dangerous infectious ...

Applied Biosystems technology helps to expand salmon conservation project

14-Jul-2005 - Assays and instruments from Applied Biosystems are being used to monitor wild salmon populations in the Pacific Ocean as part of a multinational genotyping project based at the Alaska Department of Fish and Game. The decline of populations in this area is not only a threat to regional ...

Applied Biosystems Announces Joint Research Protocol with the NCI Cohort Consortium in Study of Breast and Prostate Cancer

20-Apr-2005 - Applied Biosystems, an Applera Corporation business, announced a joint, research protocol with the Cohort Consortium of the National Cancer Institute (NCI), one of the largest cohorts performing disease association studies. The protocol is being applied to discover inherited gene variants in ...